Evidence map›Paper›PMID 24716792›Full record

ArticleClinical toxicology (Philadelphia, Pa.)2014

The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model.

M Brenner, S Benavides, S B Mahon, J Lee, D Yoon, D Mukai, M Viseroi, A Chan, J Jiang, N Narula and 3 more

Erratum issued Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Clinical toxicology (Philadelphia, Pa.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT03783091 (A Phase II Double Blind Randomized Controlled Trial of High Dose Vitamin B12 in Septic Shock), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03783091 phase2completednot on this mapstarted 2019, after this paper: background citation

A Phase II Double Blind Randomized Controlled Trial of High Dose Vitamin B12 in Septic Shock

TypeinterventionalSponsorMedical College of WisconsinRan2019 to 2023Enrolled20ConditionsSeptic ShockArmsHydroxocobalamin, Placebo
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Hydrogen Sulfide Toxicity: Mechanism of Action, Clinical Presentation, and Countermeasure Development.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2019
    Review
  9. Data-Driven Identification of Hydrogen Sulfide Scavengers.Angewandte Chemie (International ed. in English) · 2019
    Article
  10. Article
  11. Environmental toxicology of hydrogen sulfide.Nitric oxide : biology and chemistry · 2017
    Review
  12. Comparative studies of reaction of cobalamin (II) and cobinamide (II) with sulfur dioxide.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

M BrennerBeckman Laser Institute, University of California , Irvine, CA , USA.
S Benavides
S B Mahon
J Lee
D Yoon
D Mukai
M Viseroi
A Chan
J Jiang
N Narula
S M Azer
C Alexander
G R Boss
Beckman Laser Institute and Medical Clinic · USUniversity of California, Irvine · USUniversity of California, San Diego · USCornell University · US

Funding

Validating promising drug candidates in mammalian models of CN poisoningU54NS079201 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI MACRAE, CALUM A., PETERSON, RAYMOND J · 2012 to 2016
$12.6M
Pre-Clinical and Clinical Studies of Cobinamide, A New Cyanide Detoxifying AgentU01NS058030 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BOSS, GERRY R · 2006 to 2017
$7.3M
Virtual Photonocs TechnologiesP41EB015890 · NIBIB · UNIVERSITY OF CALIFORNIA-IRVINE · PI BOTVINICK, ELLIOT LAWRENCE · 2012 to 2017
$7.0M
ScientificU54NS063718 · NINDS · UNIVERSITY OF MINNESOTA · PI PATTERSON, STEVEN E · 2008 to 2011
$3.4M
Testing the Vitamin B12 Analog Cobinamide Against Selected Chemical ThreatsR21NS072105 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BOSS, GERRY R · 2011 to 2012
$774k
NIBIB NIH HHS P41 EB015890NINDS NIH HHS R21 NS072105NINDS NIH HHS U01 NS058030NINDS NIH HHS U54 NS063718NINDS NIH HHS U54 NS079201
6 · The paper itself

Abstract

background and purposeHydrogen sulfide (H2S) is a highly toxic gas for which no effective antidotes exist. It acts, at least in part, by binding to cytochrome c oxidase, causing cellular asphyxiation and anoxia. We investigated the effects of three different ligand forms of cobinamide, a vitamin B12 analog, to reverse sulfide (NaHS) toxicity.

methodsNew Zealand white rabbits received a continuous intravenous (IV) infusion of NaHS (3 mg/min) until expiration or a maximum 270 mg dose. Animals received six different treatments, administered at the time when they developed signs of severe toxicity: Group 1-saline (placebo group, N = 9); Group 2--IV hydroxocobalamin (N = 7); Group 3--IV aquohydroxocobinamide (N = 6); Group 4--IV sulfitocobinamide (N = 6); Group 5--intramuscular (IM) sulfitocobinamide (N = 6); and Group 6-IM dinitrocobinamide (N = 8). Blood was sampled intermittently, and systemic blood pressure and deoxygenated and oxygenated hemoglobin were measured continuously in peripheral muscle and over the brain region; the latter were measured by diffuse optical spectroscopy (DOS) and continuous wave near infrared spectroscopy (CWNIRS).

resultsCompared with the saline controls, all cobinamide derivatives significantly increased survival time and the amount of NaHS that was tolerated. Aquohydroxocobinamide was most effective (261.5 ± 2.4 mg NaHS tolerated vs. 93.8 ± 6.2 mg in controls, p < 0.0001). Dinitrocobinamide was more effective than sulfitocobinamide. Hydroxocobalamin was not significantly more effective than the saline control.

conclusionsCobinamide is an effective agent for inhibiting lethal sulfide exposure in this rabbit model. Further studies are needed to determine the optimal dose and form of cobinamide and route of administration.

Indexed as

AnimalsAntidotesCobamidesDisease Models, AnimalHemoglobinsHydrogen SulfideHydroxocobalaminInfusions, IntravenousInjections, IntramuscularInjections, IntravenousRabbitsSpectroscopy, Near-InfraredSulfidesSurvival RateAntidotesCobamidescobinamideHemoglobinsHydrogen SulfideHydroxocobalaminsodium bisulfideSulfidesCNS/PsychologicalHeartLungMuscle

Identifiers

PMID24716792
PMCPMC4149338
OpenAlexW2135287214

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.